ARCHIVES

ODAC Recommends Approval of Gemcitabine For Pancreatic Cancer

This article is from The Cancer Letter archive.

Vol. 21 No. 31 | August 4, 1995

Download PDF Visit The Full Archive

Related Articles

Pennsylvania Cancer Center Gets $100 Million; Watson, Weinberg, Win National Science Medals

December 19, 1997

Flavopiridol Plus Cisplatin Tested In Phase II Trial

October 26, 2007

ASCO, COA Present Plans For Cancer CareBeyond the Fee-For-Service Pay Structure

January 24, 2014

NCI-Approved Trials Listed

April 28, 2006

NCI, Dialogue Plan A National Tissue Bank

July 11, 2003

St. Jude Director Cites Poor Housing’s Toll on Children, March 28, 1971

May 19, 2021